Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Oct 5, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Sep 11, 2026Reported sale · Form 4Jack Higgins, Chief Scientific Officer · $334.2KOpen the filing ↗
- Sep 11, 2026Notice of sale · Form 144Higgins Jack · Officer · $334.2KOpen the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record41822 flagged findings
Reported transactions (Form 4)80since Aug 9, 2024 · and 18 other holdings
Corporate events (8-K)30since Sep 2, 2022
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-05-12share offering or dilution eventrecentOpen filing ↗“…in the future to continue our planned operations, including further development of our programs and product candidates, preparing IND…”
+1 more passage from the same document
- “…and development activities and costs associated with operating a public company. To raise capital, we may sell common stock,…”
- 2026-05-12Department of Justice inquiryrecentOpen filing ↗“…allegedly violating the GDPR’s cross-border data transfer limitations. 43 Table of Contents Regulators in the United States are…”
- 2026-03-03share offering or dilution eventrecentOpen filing ↗“…the future to continue our planned operaHtions, including further development of our programs and product candidates, preparing IND…”
+1 more passage from the same document
- “…and development activities and costs associated with operating a public company. To raise capital, we may sell common stock,…”
- 2026-03-03Department of Justice inquiryrecentOpen filing ↗“…out of Europe for allegedly violating the GDPR’s cross-border data transfer limitations. Regulators in the United States are…”
+1 more passage from the same document
- “…to administrative or judicial sanctions, such as FDA refusal to approve pending NDAs or BLAs, or the agency's issuance of…”
- 2026-03-03merger or acquisition eventrecentOpen filing ↗“…or are filed with this Annual Report on Form 10-K, in each case as indicated therein. 112 Table of Contents EXHIBIT INDEX Exhibit…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
The 25 most recent filings (of 418)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Oct 5, 268-K ↗Current report · Entered a material agreement
- Sep 15, 26Form 4 ↗Insider transaction
- Sep 11, 26Form 144 ↗Notice of proposed sale
- Aug 14, 26SCHEDULE 13G/A ↗Passive stake · T. Rowe Price Investment Management, Inc. · 17.4% · event on Jun 30, 26 · amendment
- Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Sirenia Capital Management LP · 4.3% · event on Jun 30, 26 · amendment
- Aug 12, 26Form 144 ↗Notice of proposed sale
- Aug 12, 26Form 4 ↗Insider transaction
- Aug 11, 2610-Q ↗Quarterly report
- Aug 11, 268-K ↗Current report · Results
Notice of proposed sale · 2 Form 144 filingsshow all 2hide
- Aug 6, 26Form 144 ↗Notice of proposed sale
- Aug 4, 26Form 144 ↗Notice of proposed sale
Insider transaction · 9 Form 4 filingsshow all 9hide
- Jul 27, 26Form 4 ↗Insider transaction
- Jul 27, 26Form 4 ↗Insider transaction
- Jul 27, 26Form 4 ↗Insider transaction
- Jul 27, 26Form 4 ↗Insider transaction
- Jul 27, 26Form 4 ↗Insider transaction
- Jul 27, 26Form 4 ↗Insider transaction
- Jul 27, 26Form 4 ↗Insider transaction
- Jul 9, 26Form 4 ↗Insider transaction
- Jul 7, 26Form 4 ↗Insider transaction
- Jul 7, 26Form 144 ↗Notice of proposed sale
- Jul 7, 26Form 4 ↗Insider transaction
- Jul 6, 26Form 144 ↗Notice of proposed sale
418 filings on record, the oldest from Sep 1, 20.
Listing the 25 most recent filings of the 418 on record.
2513
- Oct 5, 26Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Jan 23, 25A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Oct 29, 24Entered a material agreement+4 more in the same filing8-K 1.01 ↗
- Apr 30, 24A senior executive left or was appointed8-K 5.02 ↗
- Apr 25, 24A senior executive left or was appointed8-K 5.02 ↗
- Mar 26, 24Entered a material agreement+4 more in the same filing8-K 1.01 ↗
- Feb 6, 24Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Feb 1, 24A senior executive left or was appointed8-K 5.02 ↗
- Jan 8, 24Sold unregistered shares+2 more in the same filing8-K 3.02 ↗
3 senior executive changes2023 – 2024show all 3hide
- Jan 2, 24A senior executive left or was appointed8-K 5.02 ↗
- Dec 29, 23A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Nov 8, 23A senior executive left or was appointed8-K 5.02 ↗
- Oct 4, 23Entered a material agreement+7 more in the same filing8-K 1.01 ↗
- Jun 29, 23Sold unregistered shares+3 more in the same filing8-K 3.02 ↗
4 older filings not shown · The record reaches back to Dec 4, 20.
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13D: stake and stated purpose
Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.
- Immunome Aggregator, LP6.0%Jan 31, 25SCHEDULE 13D/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
- Enavate Sciences GP, LLC4.3%Dec 18, 25SCHEDULE 13D/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- T. Rowe Price Investment Management, Inc.17.4%Jun 30, 26SCHEDULE 13G/A ↗2 earlier filings
- FMR LLC15.0%Sep 30, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
- The Vanguard Group5.2%Jun 30, 25SCHEDULE 13G ↗
- Redmile Group, LLC4.9%Mar 31, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
- EcoR1 Capital, LLC4.7%Mar 31, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
show 2 more holdershide
- Sirenia Capital Management LP4.3%Jun 30, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
- JANUS HENDERSON GROUP PLC2.2%Mar 31, 25SCHEDULE 13G/A ↗
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
Sale intention announced
On Sep 11, Higgins Jack filed notice of intent to sell up to $334K. That is about 0.01% of shares outstanding. It is filed under a scheduled plan (10b5-1), arranged in advance.
A notice is not a sale: it may not go ahead, may happen in part, or at a different price.
After the notice, they sold $334K on Sep 11, per their Form 4. That is 100% of the shares announced so far, and the window is still open.
View notice (Form 144) ↗+9 more recent notices · 4 with a later sale
- Sep 11, 26Sell$334KJack HigginsChief Scientific Officer↗
- Aug 12, 26Sell$301KIsaac Barchas↗
- Aug 11, 26Sell$1.6MIsaac Barchas↗
- Aug 10, 26Sell$264KIsaac Barchas↗
- Aug 7, 26Sell$397KIsaac Barchas↗
- Aug 6, 26Sell$543KIsaac Barchas↗
- Aug 4, 26Sell$2.3MKinney HornCHIEF BUSINESS OFFICER↗
- Jul 7, 26Sell$409KIsaac Barchas↗
- Jul 7, 26Sell$27KKinney HornCHIEF BUSINESS OFFICER↗
- Jul 6, 26Sell$2.0MIsaac Barchas↗
- Jul 2, 26Sell$1.7MIsaac Barchas↗
- Jul 2, 26Sell$568KIsaac Barchas↗
There are 13 more transactions in this stretch.
Stock compensation, tax and giftsshow the 15 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Sep 11, 26Compensation$24KJack HigginsChief Scientific Officer↗
- Sep 11, 26Giftamount n/aJack HigginsChief Scientific Officer↗
- Aug 4, 26Compensation$651KKinney HornCHIEF BUSINESS OFFICER↗
- Aug 4, 26Compensation$427KKinney HornCHIEF BUSINESS OFFICER↗
- Jul 23, 26Compensationamount n/aCLAY B SIEGALLPresident and CEO↗
- Jul 23, 26Compensationamount n/aSandra G. StonemanCHIEF LEGAL OFFICER & GC↗
- Jul 23, 26Compensationamount n/aKinney HornCHIEF BUSINESS OFFICER↗
- Jul 23, 26Compensationamount n/aJack HigginsChief Scientific Officer↗
- Jul 23, 26Compensationamount n/aMax RosettChief Financial Officer↗
- Jul 23, 26Compensationamount n/aRobert LechleiderChief Medical Officer↗
- Jul 23, 26Compensationamount n/aPhilip TsaiChief Technical Officer↗
- Jul 7, 26Compensation$14KKinney HornCHIEF BUSINESS OFFICER↗
- Jul 2, 26Compensation$480KRobert LechleiderChief Medical Officer↗
- Jun 25, 26Compensation$480KRobert LechleiderChief Medical Officer↗
- Jun 15, 26Compensation$63KMax RosettChief Financial Officer↗
The full record holds 93 transactions and goes back to Jan 15, 23.
Its sector and its market
Immunome Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Immunome Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Immunome Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- 250 clean closes in the period.
- SEC records
- 418 documents on file, from Sep 1, 2020 to Oct 5, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.